Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

FluChip-8G Influenza A+B Assay

K-Number: K182513 · 2019-04-22

ApplicantIndevr, Inc.
Decision Date2019-04-22
Product CodeOZE
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

FluChip-8G Influenza A+B Assay is the device name listed in this FDA 510(k) record. The listed applicant is Indevr, Inc.. It received FDA 510(k) clearance on 2019-04-22 under 510(k) number K182513. The device is classified under product code OZE. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the FluChip-8G Influenza A+B Assay?

FluChip-8G Influenza A+B Assay is a medical device that received FDA 510(k) clearance on 2019-04-22. The listed applicant is Indevr, Inc.. The 510(k) number is K182513.

When did FluChip-8G Influenza A+B Assay receive FDA 510(k) clearance?

FluChip-8G Influenza A+B Assay received FDA 510(k) clearance on 2019-04-22, under 510(k) number K182513.

Who is the listed applicant for FluChip-8G Influenza A+B Assay?

The FDA 510(k) record lists Indevr, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for FluChip-8G Influenza A+B Assay?

The FDA product code for FluChip-8G Influenza A+B Assay is OZE.

Related Devices (Code: OZE)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.